胸腺基质淋巴细胞生成素
炎症
自噬
免疫学
发病机制
哮喘
免疫系统
过敏性炎症
医学
细胞因子
生物
细胞凋亡
生物化学
作者
Jiping Zhao,Jintao Zhang,Shuangmei Tang,Junfei Wang,Tian Liu,Rong Zeng,Weiping Zhu,Kang‐Da Zhang,Jinxiang Wu
出处
期刊:Immunobiology
[Elsevier BV]
日期:2021-09-01
卷期号:226 (5): 152124-152124
被引量:1
标识
DOI:10.1016/j.imbio.2021.152124
摘要
Asthma is a chronic respiratory disease characterized by airway inflammation and remodeling as well as hyper-responsiveness. Thymic stromal lymphopoietin (TSLP), which is a crucial inflammatory cytokine in immune homeostasis, consists of two isoforms, the long isoform lfTSLP and short isoform sfTSLP. The lfTSLP promotes inflammation and plays a pivotal role in asthma pathogenesis, while sfTSLP had been reported to have anti-asthma effects. Experiments have shown that lfTSLP could induce autophagy in hepatocytes. It is unknown whether lfTSLP or sfTSLP could influence autophagy and affect the progression of asthma. Using house dust mite (HDM)-stimulated airway smooth muscle cells as an in vitro model and HDM-induced asthma mice as in vivo model, we found that lfTSLP could induce autophagy and remodeling, while sfTSLP has the reverse effect. Strikingly, sfTSLP treatment in vivo reversed HDM-mediated activation of inflammation and airway remodeling, partly determined by autophagy change. These findings may help us understand the function of TSLP isoforms in the pathogenesis of asthma, and they support the use of drugs targeting sfTSLP and TSLP for asthma treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI